Lupvindol Biosciences
Lupvindol Biosciences is a US startup, founded in 2024. It has raised at least $2.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Lupvindol Biosciences has raised at least $2.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
Questions and answers
What does Lupvindol Biosciences do?
Lupvindol Biosciences is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Lupvindol Biosciences raised?
At least $2.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Lupvindol Biosciences based?
Lupvindol Biosciences is registered in United States; its operating headquarters is not yet confirmed.
When was Lupvindol Biosciences founded?
Lupvindol Biosciences was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.